Get Your Personalized Supplement StackSupplement Stack Quiz

Vitamina K

Also known as: Vitamina K, Phylloquinone, Vitamin K1, Menaquinone, Vitamin K2, Menadione, Vitamin K3, Vitamin K

Overview

Vitamin K is a group of fat-soluble vitamins essential for various physiological processes, primarily blood coagulation and bone metabolism. It exists in several forms, including phylloquinone (Vitamin K1), found abundantly in green leafy vegetables, and menaquinones (Vitamin K2), which are present in fermented foods and produced by gut bacteria. A synthetic form, menadione (Vitamin K3), also exists. Vitamin K acts as a crucial cofactor for the gamma-carboxylation of specific proteins, enabling their biological activity. Its primary applications include supporting healthy blood clotting, maintaining bone mineral density, and potentially inhibiting vascular calcification, thereby contributing to cardiovascular health. Research on Vitamin K, particularly K2, is well-established with numerous randomized controlled trials and meta-analyses supporting its benefits, especially for bone and cardiovascular outcomes. While generally safe, its interaction with anticoagulant medications requires careful consideration.

Benefits

Vitamin K offers significant evidence-based benefits, particularly for bone and cardiovascular health. For bone health, Vitamin K2 supplementation has been shown to significantly improve bone mineral density (BMD) and reduce fracture risk, especially in postmenopausal women. Meta-analyses indicate positive effects on lumbar spine BMD and fracture prevention, with good quality evidence supporting these outcomes. In cardiovascular health, Vitamin K supplementation reduces levels of dephosphorylated-uncarboxylated matrix Gla protein (dp-ucMGP), a marker of vascular calcification, suggesting a role in slowing vascular calcification progression. While its effects on traditional cardiovascular risk factors like lipids or CRP are generally non-significant, K2 may modestly reduce insulin resistance (HOMA-IR). Postmenopausal women and patients with chronic kidney disease or those on hemodialysis may benefit most from Vitamin K supplementation due to its effects on bone and vascular calcification, respectively. The time course for benefits typically ranges from months to years, with bone health improvements observed over longer periods.

How it works

Vitamin K functions as an essential cofactor for the enzyme gamma-glutamyl carboxylase. This enzyme is responsible for the post-translational modification of specific proteins, known as vitamin K-dependent proteins, by adding a carboxyl group to their glutamate residues. This carboxylation is crucial for these proteins to become biologically active. Key vitamin K-dependent proteins include those involved in the coagulation cascade (e.g., prothrombin) and bone metabolism (e.g., osteocalcin) and vascular health (e.g., matrix Gla protein, MGP). By activating osteocalcin, Vitamin K supports bone mineralization, and by activating MGP, it helps inhibit calcium deposition in arterial walls. As a fat-soluble vitamin, it is absorbed in the small intestine in the presence of dietary fats, with K2 forms generally exhibiting better bioavailability and longer half-lives than K1.

Side effects

Vitamin K is generally considered safe, with no serious adverse events commonly reported in clinical trials at typical supplemental doses. Common side effects, though infrequent, may include mild gastrointestinal discomfort. Rare instances of allergic reactions have been noted. There is no established upper limit for Vitamin K, and doses up to several milligrams per day have been used safely in research settings. However, a critical safety consideration is its interaction with anticoagulant medications, particularly vitamin K antagonists like warfarin. Vitamin K can counteract the effects of these drugs, potentially reducing their efficacy and increasing the risk of blood clots. Therefore, patients on such medications should consult their healthcare provider before taking Vitamin K supplements and may require careful monitoring of their coagulation status. Contraindications include hypersensitivity to Vitamin K. Caution is also advised for individuals with bleeding disorders, though this is primarily due to the potential for interaction with anticoagulant therapies rather than direct adverse effects of Vitamin K itself.

Dosage

The optimal dosage of Vitamin K varies depending on the specific form and the desired health outcome. For bone health and osteoporosis prevention, studies often utilize Vitamin K2 (menaquinone-7) in doses ranging from 90 to 180 mcg per day, which has shown effectiveness in improving bone mineral density and reducing fracture risk. Doses for addressing vascular calcification can vary widely in research, but similar ranges are often explored. There is no established upper limit for Vitamin K, and doses up to several milligrams per day have been safely used in clinical trials without reported toxicity. As a fat-soluble vitamin, Vitamin K is best absorbed when taken with meals containing dietary fat. Vitamin K2, particularly menaquinone-7, is generally preferred over K1 for bone and cardiovascular benefits due to its superior bioavailability and longer half-life in the body. Adequate intake of Vitamin D and calcium may synergistically enhance the bone health benefits of Vitamin K.

FAQs

Is vitamin K supplementation safe?

Yes, Vitamin K is generally safe with minor gastrointestinal side effects. However, caution is advised if you are taking blood thinners like warfarin, as it can interfere with their effectiveness.

Does vitamin K improve cardiovascular health?

Vitamin K may help reduce markers of vascular calcification, suggesting a role in arterial health. However, its effect on traditional cardiovascular risk factors like cholesterol or blood pressure is limited.

How long before benefits appear?

Benefits, especially for bone health, typically require long-term supplementation, often taking several months to years to become noticeable. Vascular effects also require sustained use.

Which form is best?

Vitamin K2, particularly menaquinone-7 (MK-7), is generally considered the most effective form for bone and cardiovascular health due to its better bioavailability and longer half-life in the body.

Can vitamin K reverse osteoporosis?

While Vitamin K helps reduce bone loss and fracture risk, it is not a standalone treatment for reversing established osteoporosis. It should be part of a comprehensive bone health strategy.

Research Sources

https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2023.1115069/full – This systematic review and meta-analysis found that Vitamin K supplementation significantly reduces levels of dp-ucMGP, a marker of vascular calcification, across various populations, including hemodialysis patients. The results were stable across sensitivity analyses, indicating a potential role for Vitamin K in mitigating vascular calcification, despite high heterogeneity among studies.
https://pubmed.ncbi.nlm.nih.gov/38282652/ – This systematic review and meta-analysis of 17 RCTs concluded that Vitamin K supplementation modestly reduces HOMA-IR (a measure of insulin resistance) but showed no significant effect on other metabolic markers like lipids, CRP, or glucose. The study highlighted that K2 was more effective than K1 in influencing insulin resistance, despite heterogeneity in study designs.
https://www.cambridge.org/core/journals/journal-of-nutritional-science/article/effect-of-vitamin-k-supplementation-on-cardiovascular-risk-factors-a-systematic-review-and-metaanalysis/0F16EF6952E35875EE28AC0DA5974B5E – This systematic review and meta-analysis examined the effect of Vitamin K supplementation on cardiovascular risk factors. It found a modest but statistically significant reduction in HOMA-IR, indicating an improvement in insulin sensitivity. However, it reported no significant effects on other traditional cardiovascular risk factors such as lipids, CRP, or glucose levels, except for insulin resistance.
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/410550 – This systematic review and meta-analysis investigated the effects of Vitamin K supplementation on bone health and fracture risk. It concluded that Vitamin K supplementation reduces fracture risk and improves bone health, particularly in postmenopausal women and the elderly. The study also noted that no serious adverse events were reported, supporting the safety of Vitamin K for bone health.
https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.979649/full – This systematic review and meta-analysis focused on the effects of Vitamin K2 supplementation on postmenopausal osteoporosis. It found that VK2 supplementation significantly improves lumbar spine bone mineral density (BMD) and reduces fracture risk. The findings were consistent across studies, despite some variability in dose and duration, supporting VK2's role in bone health.